844
Views
0
CrossRef citations to date
0
Altmetric
Editorial

COVert IDentities of current worldwide pandemic

, &

References

  • WHO. 2003. Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003.
  • World Health Organization. 2021. COVID-19 Weekly Epidemiological Update 22.
  • Zhou Z, Yang Z, Ou J, et al. Temperature dependence of the SARS-CoV-2 affinity to human ACE2 determines COVID-19 progression and clinical outcome. Comput Struct Biotechnol J. 2021;19:161–167. doi:10.1016/j.csbj.2020.12.005.
  • Forster P, Forster L, Renfrew C, Forster M. Phylogenetic network analysis of SARS-CoV-2 genomes. Proc Natl Acad Sci USA. 2020;117(17):9241–9243. doi:10.1073/pnas.2004999117.
  • Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. 2020;180(7):934–943. 1doi:10.1001/jamainternmed.2020.0994.
  • Emerging human coronavirus infections (SARS, MERS, and COVID-19): Where they are leading us. Int Rev Immunol 2021;40(1-2):5–53. doi:10.1080/08830185.2021.1800688.
  • Pathogenesis guided therapeutic management of COVID-19: an immunological perspective. Int Rev Immunol 2021;40(1-2):54–71. doi:10.1080/08830185.2021.1840566.
  • Singhal T. A review of Coronavirus Disease-2019 (COVID-19). Indian J Pediatr. 2020;87(4):281–286. doi:10.1007/s12098-020-03263-6.
  • How could we forget immunometabolism in SARS-CoV2 infection or COVID-19? Int Rev Immunol 2021;40(1-2):72–107. doi:10.1080/08830185.2021.1840567.
  • Dendritic cells in COVID-19 immunopathogenesis: insights for a possible rolein determining disease outcome. Int Rev Immunol 2021;40(1-2):108–125. doi:10.1080/08830185.2021.1844195.
  • Zhou R, To KK, Wong YC, et al. Acute SARS-CoV-2 infection impairs dendritic cell and T Cell responses. Immunity. 2020;53(4):864–877.e5. doi:10.1016/j.immuni.2020.07.026.
  • Rapid diagnosis of SARS-CoV-2 using potential point-of-care electrochemical immunosensor: Towards the future prospects. Int Rev Immunol 2021;40(1-2):126–142. doi:10.1080/08830185.2021.1872566.
  • Molecular Diagnostic Tools for the Detection of SARS-CoV-2. Int Rev Immunol 2021;40(1-2):143–156. doi:10.1080/08830185.2021.1871477.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.